Incentives, Cognitive Training and Internet Therapy for Teens With Poorly Controlled Type 1 Diabetes
Type 1 Diabetes
About this trial
This is an interventional supportive care trial for Type 1 Diabetes
Eligibility Criteria
Inclusion Criteria:
- 13-17 years old
- Diagnosis of type 1 diabetes
- Average HbA1c > or = to 8% for the past 6 months (mean of two values)
- Most recent HbA1c is > or = to 8%
- Duration of disease is > 18 months
- Teen must live at home
- Family must have broadband internet in the home
Exclusion Criteria:
- Pregnancy/breast feeding
- Active psychosis
- Severe medical or psychiatric illness that will limit participation
Sites / Locations
- Dartmouth College
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
MAxIM
Usual Care
This new intervention, called MAxIM (MotivAtion, Incentives, Memory) uses: 1) motivation enhancement therapy (MET) (an existing evidence-based treatment for adolescent with diabetes) supplemented with cognitive behavior therapy (CBT) to enhance behavior change; 2) financial incentives for daily blood glucose testing and parental monitoring to provide frequent positive feedback; and 3) working memory training (WMT), a method for strengthening specific cognitive processes that support decision-making and future orientation. The interventions will be delivered to families at home via the internet.
Usual Care reflects the standard treatment currently provided at the Children's Hospital at Dartmouth. Teens will be followed by their treating endocrinologist and receive the following standard services as part of that treatment-quarterly outpatient clinic visits, including an interval medical history and physical examination; routine laboratory assessment; review of glycemic control, medication adjustment, medical nutrition therapy, and diabetes self-management education; telephone consultations with a nurse/certified diabetes educator in their treating clinic are available as often as necessary between clinic visits.